Table 4.
Consensus agreement of the delphi phases
| Phase 1 | Phase 2 | |||||
| Percentage agreement | Scores <3 | Consensus reached? | Percentage agreement | Consensus reached? | ||
| Headline messages | Impact Statement 1 | 95% | 0 | Yes* | High—95% | Yes |
| Impact Statement 2 | 94% | 0 | Yes* | High—94% | Yes | |
| Impact Statement 3 | 88% | 3 | No | High—94% | Yes | |
| Impact Statement 4 | N/A | High—89% | Yes | |||
| Symptom statements | Musculoskeletal pain | 92% | 1 | No | High—94% | Yes |
| Fatigue | 91% | 2 | No | High—93% | Yes | |
| Shortness of breath | 92% | 1 | No | High—97% | Yes | |
| Cardiac chest pain | 89% | 1 | No | High—94% | Yes | |
| Palpitations | 95% | 0 | Yes | |||
| Dysglycaemia | 90% | 0 | Yes* | High—89% | Yes | |
| Cognitive impairment | 88% | 2 | No | High—95% | Yes | |
| Falls and frailty | 95% | 0 | Yes | |||
*Despite meeting agreement in phase 1, phase 2 re-tested these statements due to substantial wording changes.